Currently, a number of vaccines or antiviral drugs for COVID-19 have been approved or are under development, and patients are currently treated symptomatically. For both vaccines and therapeutics, the antibodies produced are tested for their functional efficacy to neutralize the target virus.    The cell-based assays market is projected to reach USD 22.0 billion by 2025, at a CAGR of...